The preponderance of P450s in the Mycobacterium tuberculosis genome

Trends in Microbiology

Volumn 14, Issue 5, 2006, Pages 220-228

  McLean, Kirsty J ^a   Clift, Daniel ^a   Lewis, D Geraint ^a   Sabri, Muna ^a   Balding, Philip R ^a   Sutcliffe, Michael J ^a   Leys, David ^a   Munro, Andrew W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CYTOCHROME P450; CYTOCHROME P450 121; CYTOCHROME P450 124; CYTOCHROME P450 125; CYTOCHROME P450 128; CYTOCHROME P450 130; CYTOCHROME P450 132; CYTOCHROME P450 136; CYTOCHROME P450 141; CYTOCHROME P450 144; CYTOCHROME P450 INHIBITOR; STEROL 14ALPHA DEMETHYLASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ANTIBACTERIAL ACTIVITY; BACTERIAL GENOME; CYTOLOGY; ENZYME ANALYSIS; ENZYME STRUCTURE; GENE SEQUENCE; GENETIC CODE; GENOME ANALYSIS; HUMAN; KNOCKOUT GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

BACTERIAL PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; ISOENZYMES; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; OXIDATION-REDUCTION; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA;

EID: 33646531629     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2006.03.002     Document Type: Review

References (57)

1. Cole S.T., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
2. Brosch R., et al. The evolution of mycobacterial pathogenicity: clues from comparative genomics. Trends Microbiol. 9 (2001) 452-458
3. Saint-Joanis B., et al. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem. J. 338 (1999) 753-760
4. Brennan M.J., et al. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect. Immun. 69 (2001) 7326-7333
5. Brennan M.J., and Delogu J. The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbiol. 10 (2002) 246-249
6. Kolattukudy P.E., et al. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol. Microbiol. 24 (1997) 263-270
7. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 83 (2003) 91-97
8. Munro A.W., and Lindsay J.G. Bacterial cytochromes P450. Mol. Microbiol. 20 (1996) 1115-1125
9. Denisov I.G., et al. Structure and chemistry of cytochrome P450. Chem. Rev. 105 (2005) 2253-2277
10. Venter J.C., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
11. Bellamine A., et al. Characterization and catalytic properties of the sterol 14α-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8937-8942
12. Odds F.C., et al. Antifungal agents: mechanisms of action. Trends Microbiol. 11 (2003) 272-279
13. Nagano S., et al. Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF. J. Biol. Chem. 280 (2005) 22102-22107
14. Warman A.J., et al. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme. Biochem. Soc. Trans. 33 (2005) 747-753
15. Guengerich F.P. Cytochromes P450, drugs, and diseases. Mol. Interv. 3 (2003) 194-204
16. Cupp-Vickery J.R., et al. Substrate-assisted catalysis in cytochrome P450eryF. Nat. Struct. Biol. 3 (1996) 632-637
17. Urlacher V.B., et al. Microbial P450 enzymes in biotechnology. Appl. Microbiol. Biotechnol. 64 (2004) 317-325
18. Rezen T., et al. New aspects on lanosterol 14α-demethylase and cytochrome P450 evolution: lanosterol/cycloartenol diversification and lateral transfer. J. Mol. Evol. 59 (2004) 51-58
19. Lamb D.C., et al. A sterol biosynthetic pathway in Mycobacterium. FEBS Lett. 437 (1998) 142-144
20. Gatfield J., and Pieters J. Essential role for cholesterol in the entry of mycobacteria into macrophages. Science 288 (2000) 1647-1650
21. Okita R.T., and Okita J.R. Cytochrome P450 4A fatty acid ω-hydroxylases. Curr. Drug Metab. 2 (2001) 265-281
22. Recchi C., et al. Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome p450 regulation. J. Biol. Chem. 278 (2003) 33763-33773
23. Sun Y., et al. A complete gene cluster from Streptomyces nanchangensis NS3226 encoding biosynthesis of the polyether ionophore nanchangmycin. Chem. Biol. 10 (2003) 431-441
24. Leys D., et al. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 Å reveals novel features of cytochrome P450. J. Biol. Chem. 278 (2003) 5141-5147
25. McLean K.J., et al. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis. J. Inorg. Biochem. 91 (2002) 527-541
26. McLean K.J., et al. Azole antifungals are potent inhibitors of cytochrome P450 monooxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology. 148 (2002) 2937-2949
27. Mahairas G.G., et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178 (1996) 1274-1282
28. Sherman D.R., et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7534-7539
29. Fisher M.A., et al. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 184 (2002) 4025-4032
30. Müller J.J., et al. Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem. 276 (2001) 2786-2789
31. Munro A.W., et al. Determination of the redox properties of human NADPH-cytochrome P450 reductase. Biochemistry 40 (2001) 1956-1963
32. + revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase. Biochemistry 41 (2002) 8807-8818
33. McLean K.J., et al. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. Biochem. J. 372 (2003) 317-327
34. Munro A.W., et al. P450 BM3: the very model of a modern flavocytochrome. Trends Biochem. Sci. 27 (2002) 250-257
35. Sevrioukova I.F., et al. Crystal structure of putidaredoxin, the [2Fe-2S] component of the P450cam monooxygenase system from Pseudomonas putida. J. Mol. Biol. 333 (2003) 377-392
36. Sielaff B., and Andreesen J.R. Kinetic and binding studies with purified recombinant proteins ferredoxin reductase, ferredoxin and cytochrome P450 comprising the morpholine mono-oxygenase from Mycobacterium sp. strain HE5. FEBS J. 272 (2005) 1148-1159
37. Green A.J., et al. Expression, purification and characterisation of a Bacillus subtilis ferredoxin: a potential electron transfer donor to cytochrome P450 BioI. J. Inorg. Biochem. 93 (2003) 92-99
38. McLean K.J., et al. Biodiversity of cytochrome P450 redox systems. Biochem. Soc. Trans. 33 (2005) 796-801
39. Zanno A., et al. MT FdR: a ferredoxin reductase from M. tuberculosis that couples to MT CYP51. Biochim. Biophys. Acta 1707 (2005) 157-169
40. Podust L.M., et al. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3068-3073
41. Podust L.M., et al. Estriol bound and ligand-free structures of sterol 14α-demethylase. Structure 12 (2004) 1937-1945
42. Boshoff H.I.M., et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J. Biol. Chem. 279 (2004) 40174-40184
43. Nelson D.R. Cytochrome P450 and the individuality of species. Arch. Biochem. Biophys. 369 (1999) 1-10
44. Gamieldien J., et al. Eukaryotic genes in Mycobacterium tuberculosis could have a role in pathogenesis and immunomodulation. Trends Genet. 18 (2002) 5-8
45. Kelly S.L., et al. The diversity and importance of microbial cytochromes P450. In: Ortiz de Montellano P.R. (Ed). Cytochrome P450: Structure, Mechanism and Biochemistry. 3rd edn (2005), Kluwer Academic/Plenum Publishers 585-617
46. Cole S.T., et al. Massive gene decay in the leprosy bacillus. Nature 409 (2001) 1007-1011
47. Garnier T., et al. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7877-7882
48. Burguière A., et al. Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole. Microbiology 151 (2005) 2087-2095
49. Sassetti C.M., et al. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48 (2003) 77-84
50. Waddell S.J., et al. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinb.) 84 (2004) 263-274
51. Kendall S.L., et al. What do microarrays really tell us about M. tuberculosis?. Trends Microbiol. 12 (2004) 537-544
52. Schnappinger D., et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198 (2003) 693-704
53. Park H.D., et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48 (2003) 833-843
54. Betts J.C., et al. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47 (2003) 2903-2913
55. Stewart G.R., et al. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 148 (2002) 3129-3138
56. Tsolaki A.G., et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4865-4870
57. Sassetti C.M., and Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12989-12994